Status:
COMPLETED
Lipid Profile and Diabetes Mellitus in People With HIV
Lead Sponsor:
Moritz Oberndorfer
Collaborating Sponsors:
Merck Gesellschaft mbH, Austria
Conditions:
HIV Infections
Dyslipidemias
Eligibility:
All Genders
18+ years
Brief Summary
Traditional risk factors for cardiovascular diseases have been shown to have an even higher impact in the HIV infected population. The original study from 2014 was a cross sectional study into the pre...
Detailed Description
Background: In developed countries, an increase in cardiovascular events and related mortality has been seen; even more prominent in people living with HIV (PLWHIV) as compared to non-HIV control grou...
Eligibility Criteria
Inclusion
- Only Participants who participated in the previous study
- Adult (older than 18 years)
- male and female patients diagnosed and confirmed HIV diagnosis, given written informed consent
Exclusion
- No participation in the original study
Key Trial Info
Start Date :
August 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 28 2023
Estimated Enrollment :
450 Patients enrolled
Trial Details
Trial ID
NCT04125784
Start Date
August 1 2021
End Date
February 28 2023
Last Update
March 31 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Schalk:Pichler Gruppenpraxis
Vienna, Austria, 1090